Efficacy and Safety of Topical Timolol Eye Drops in the Treatment of Myopic Regression after Laser In Situ Keratomileusis: A Systematic Review and Meta-Analysis

Aims. The aim of this study was to assess the efficacy and safety of timolol in the treatment of myopic regression after laser in situ keratomileusis (LASIK). Methods. We searched MEDLINE, CENTRAL, EMBASE, China National Knowledge Infrastructure (CNKI), and Chinese Biological Medicine (CBM) from the...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaochen Wang, Guiqiu Zhao, Jing Lin, Nan Jiang, Qian Wang, Qiang Xu
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2015/985071
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562005946400768
author Xiaochen Wang
Guiqiu Zhao
Jing Lin
Nan Jiang
Qian Wang
Qiang Xu
author_facet Xiaochen Wang
Guiqiu Zhao
Jing Lin
Nan Jiang
Qian Wang
Qiang Xu
author_sort Xiaochen Wang
collection DOAJ
description Aims. The aim of this study was to assess the efficacy and safety of timolol in the treatment of myopic regression after laser in situ keratomileusis (LASIK). Methods. We searched MEDLINE, CENTRAL, EMBASE, China National Knowledge Infrastructure (CNKI), and Chinese Biological Medicine (CBM) from the inception to July 2015 for relevant randomized controlled trials that examined timolol therapy for myopic regression. The methodological quality of the studies included was assessed using the Revman 5.3 software. Results. We included six clinical trials involving 483 eyes in this review, including 246 eyes in treated group and 237 eyes in controlled group. We observed statistically significant improvements on the postoperative SE in the 3 months. However, the change of CCT was not statistically different between the control group and the experimental group. There were fewer cases of IOP, UDVA, and CDVA in treated group having significant difference from the controlled group. Conclusions. Topical timolol could be an effective treatment for reduction of myopic regression especially the spherical errors after myopic LASIK. Further RCTs with larger sample sizes for these trials are warranted to determine the efficacy and limitation for myopic regression after LASIK.
format Article
id doaj-art-c9ae3571528d4ff08209dd43ffd153be
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-c9ae3571528d4ff08209dd43ffd153be2025-02-03T01:23:42ZengWileyJournal of Ophthalmology2090-004X2090-00582015-01-01201510.1155/2015/985071985071Efficacy and Safety of Topical Timolol Eye Drops in the Treatment of Myopic Regression after Laser In Situ Keratomileusis: A Systematic Review and Meta-AnalysisXiaochen Wang0Guiqiu Zhao1Jing Lin2Nan Jiang3Qian Wang4Qiang Xu5Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao 266000, ChinaDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao 266000, ChinaDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao 266000, ChinaDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao 266000, ChinaDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao 266000, ChinaDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao 266000, ChinaAims. The aim of this study was to assess the efficacy and safety of timolol in the treatment of myopic regression after laser in situ keratomileusis (LASIK). Methods. We searched MEDLINE, CENTRAL, EMBASE, China National Knowledge Infrastructure (CNKI), and Chinese Biological Medicine (CBM) from the inception to July 2015 for relevant randomized controlled trials that examined timolol therapy for myopic regression. The methodological quality of the studies included was assessed using the Revman 5.3 software. Results. We included six clinical trials involving 483 eyes in this review, including 246 eyes in treated group and 237 eyes in controlled group. We observed statistically significant improvements on the postoperative SE in the 3 months. However, the change of CCT was not statistically different between the control group and the experimental group. There were fewer cases of IOP, UDVA, and CDVA in treated group having significant difference from the controlled group. Conclusions. Topical timolol could be an effective treatment for reduction of myopic regression especially the spherical errors after myopic LASIK. Further RCTs with larger sample sizes for these trials are warranted to determine the efficacy and limitation for myopic regression after LASIK.http://dx.doi.org/10.1155/2015/985071
spellingShingle Xiaochen Wang
Guiqiu Zhao
Jing Lin
Nan Jiang
Qian Wang
Qiang Xu
Efficacy and Safety of Topical Timolol Eye Drops in the Treatment of Myopic Regression after Laser In Situ Keratomileusis: A Systematic Review and Meta-Analysis
Journal of Ophthalmology
title Efficacy and Safety of Topical Timolol Eye Drops in the Treatment of Myopic Regression after Laser In Situ Keratomileusis: A Systematic Review and Meta-Analysis
title_full Efficacy and Safety of Topical Timolol Eye Drops in the Treatment of Myopic Regression after Laser In Situ Keratomileusis: A Systematic Review and Meta-Analysis
title_fullStr Efficacy and Safety of Topical Timolol Eye Drops in the Treatment of Myopic Regression after Laser In Situ Keratomileusis: A Systematic Review and Meta-Analysis
title_full_unstemmed Efficacy and Safety of Topical Timolol Eye Drops in the Treatment of Myopic Regression after Laser In Situ Keratomileusis: A Systematic Review and Meta-Analysis
title_short Efficacy and Safety of Topical Timolol Eye Drops in the Treatment of Myopic Regression after Laser In Situ Keratomileusis: A Systematic Review and Meta-Analysis
title_sort efficacy and safety of topical timolol eye drops in the treatment of myopic regression after laser in situ keratomileusis a systematic review and meta analysis
url http://dx.doi.org/10.1155/2015/985071
work_keys_str_mv AT xiaochenwang efficacyandsafetyoftopicaltimololeyedropsinthetreatmentofmyopicregressionafterlaserinsitukeratomileusisasystematicreviewandmetaanalysis
AT guiqiuzhao efficacyandsafetyoftopicaltimololeyedropsinthetreatmentofmyopicregressionafterlaserinsitukeratomileusisasystematicreviewandmetaanalysis
AT jinglin efficacyandsafetyoftopicaltimololeyedropsinthetreatmentofmyopicregressionafterlaserinsitukeratomileusisasystematicreviewandmetaanalysis
AT nanjiang efficacyandsafetyoftopicaltimololeyedropsinthetreatmentofmyopicregressionafterlaserinsitukeratomileusisasystematicreviewandmetaanalysis
AT qianwang efficacyandsafetyoftopicaltimololeyedropsinthetreatmentofmyopicregressionafterlaserinsitukeratomileusisasystematicreviewandmetaanalysis
AT qiangxu efficacyandsafetyoftopicaltimololeyedropsinthetreatmentofmyopicregressionafterlaserinsitukeratomileusisasystematicreviewandmetaanalysis